Cargando…
Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
Roughly a third of the world’s population is estimated to have latent Mycobacterium tuberculosis infection, being at risk of developing active tuberculosis (TB) during their lifetime. Given the inefficacy of prophylactic measures and the increase of drug-resistant M. tuberculosis strains, there is a...
Autores principales: | Nunes, José E. S., Duque, Mario A., de Freitas, Talita F., Galina, Luiza, Timmers, Luis F. S. M., Bizarro, Cristiano V., Machado, Pablo, Basso, Luiz A., Ducati, Rodrigo G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144000/ https://www.ncbi.nlm.nih.gov/pubmed/32168746 http://dx.doi.org/10.3390/molecules25061259 |
Ejemplares similares
-
Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments
por: Freitas de Freitas, Talita, et al.
Publicado: (2022) -
The Mode of Action of Recombinant Mycobacterium tuberculosis Shikimate Kinase: Kinetics and Thermodynamics Analyses
por: Rosado, Leonardo Astolfi, et al.
Publicado: (2013) -
Observed crowding effects on Mycobacterium tuberculosis 2-trans-enoyl-ACP (CoA) reductase enzyme activity are not due to excluded volume only
por: Rotta, Mariane, et al.
Publicado: (2017) -
The conserved Lysine69 residue plays a catalytic role in Mycobacterium tuberculosis shikimate dehydrogenase
por: Rodrigues, Valnês S, et al.
Publicado: (2009) -
8-Mercaptoguanine-based inhibitors of Mycobacterium tuberculosis dihydroneopterin aldolase: synthesis, in vitro inhibition and docking studies
por: Czeczot, Alexia de Matos, et al.
Publicado: (2021)